Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Thomas

Showing results (131-140 of 217) with videos related to

Pageof 22
Sort By:
Virchows Archiv : an International Journal of Pathology|June 9, 2012
A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regionsFlorence Pedeutour, Georges Maire, Anne Pierron, et al.
JCO Precision Oncology|February 13, 2026
Exceptional Response to Durvalumab and Tremelimumab in Pancreatic Acinar Cell Carcinoma With Ultramutated Phenotype Associated With a DNA Polymerase-ε MutationBenjamin Koh, Subotheni Thavaneswaran, Frank Lin, et al.
Journal of Genetic Counseling|July 4, 2021
Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing studyPhyllis Butow, Grace Davies, Christine E Napier, et al.
JAMA Network Open|May 15, 2020
Assessment of the Value of Tumor Variation Profiling Perceived by Patients With CancerPhyllis Butow, Grace Davies, Christine E Napier, et al.
BMC Cancer|December 11, 2013
The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblastsPratiti Bandopadhayay, Anissa M Jabbour, Christopher Riffkin, et al.
Psycho-Oncology|July 9, 2021
Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profilingPhyllis Butow, Fabiola Müller, Christine E Napier, et al.
Sarcoma|March 28, 2013
Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma CellsJason E Cain, Andrew McCaw, W Samantha N Jayasekara, et al.
Patient Education and Counseling|February 14, 2022
Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patientsPhyllis N Butow, Megan C Best, Grace Davies, et al.
Genetics in Medicine Open|December 13, 2024
Increased frequency of <i>CHEK2</i> germline pathogenic variants among individuals with dermatofibrosarcoma protuberansMichael R Sargen, Jung Kim, Jeremy S Haley, et al.
Cancer Discovery|September 19, 2019
Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23Maya Kansara, Kristian Thomson, Puiyi Pang, et al.
Pageof 22

Showing results (131-140 of 217) with videos related to

Sort By:
Pageof 22
Virchows Archiv : an International Journal of Pathology|June 9, 2012
A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regionsFlorence Pedeutour, Georges Maire, Anne Pierron, et al.
JCO Precision Oncology|February 13, 2026
Exceptional Response to Durvalumab and Tremelimumab in Pancreatic Acinar Cell Carcinoma With Ultramutated Phenotype Associated With a DNA Polymerase-ε MutationBenjamin Koh, Subotheni Thavaneswaran, Frank Lin, et al.
Journal of Genetic Counseling|July 4, 2021
Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing studyPhyllis Butow, Grace Davies, Christine E Napier, et al.
JAMA Network Open|May 15, 2020
Assessment of the Value of Tumor Variation Profiling Perceived by Patients With CancerPhyllis Butow, Grace Davies, Christine E Napier, et al.
BMC Cancer|December 11, 2013
The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblastsPratiti Bandopadhayay, Anissa M Jabbour, Christopher Riffkin, et al.
Psycho-Oncology|July 9, 2021
Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profilingPhyllis Butow, Fabiola Müller, Christine E Napier, et al.
Sarcoma|March 28, 2013
Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma CellsJason E Cain, Andrew McCaw, W Samantha N Jayasekara, et al.
Patient Education and Counseling|February 14, 2022
Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patientsPhyllis N Butow, Megan C Best, Grace Davies, et al.
Genetics in Medicine Open|December 13, 2024
Increased frequency of <i>CHEK2</i> germline pathogenic variants among individuals with dermatofibrosarcoma protuberansMichael R Sargen, Jung Kim, Jeremy S Haley, et al.
Cancer Discovery|September 19, 2019
Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23Maya Kansara, Kristian Thomson, Puiyi Pang, et al.
Pageof 22